Skip to main content
OpenTrials

Clinical trial condition

Locally Advanced or Metastatic Solid Tumors for Phase 1, Dose Escalation and Phase 2 Safety Lead-in

Explore clinical trials studying Locally Advanced or Metastatic Solid Tumors for Phase 1, Dose Escalation and Phase 2 Safety Lead-in. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Locally Advanced or Metastatic Solid Tumors for Phase 1, Dose Escalation and Phase 2 Safety Lead-in trial results

Completed

Study of Surzebiclimab (BGB-A425) and Alcestobart (LBL-007) in Combination With Tislelizumab in Advanced Solid Tumors

NCT03744468

Conditions
HNSCC for Phase 2 Dose Expansion, Locally Advanced or Metastatic Solid Tumors for Phase 1, Dose Escalation and Phase 2 Safety Lead-in, NSCLC for Phase 2 Dose Expansion
Locations
  • Chao Family Comprehensive Cancer Center Orange, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • University of Kentucky Markey Cancer Center Lexington, Kentucky, United States
View all 40 locations
View Trial Details

Related conditions